Adial Pharmaceuticals
Advertisement
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company based in Charlottesville, VA, dedicated to developing treatments for addictions and other unmet medical needs. Their lead investigational drug candidate, AD04, is a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD) currently undergoing a pivotal Phase 3 clinical trial.
Under the leadership of CEO Cary Claiborne, Adial Pharmaceuticals is focused on advancing precision medicine approaches in substance use treatment, with a particular emphasis on addressing the challenges of AUD through innovative research and development efforts.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement